Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation

Background A Western diet is a risk factor for the development of inflammatory bowel disease (IBD). High levels of fecal deoxycholic acid (DCA) in response to a Western diet contribute to bowel inflammatory injury. However, the mechanism of DCA in the natural course of IBD development remains unansw...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Digestive diseases and sciences 2021-02, Vol.66 (2), p.568-576
Hauptverfasser: Xu, Mengque, Cen, Mengsha, Shen, Yuqin, Zhu, Yubin, Cheng, Fangli, Tang, Linlin, Hu, Weiling, Dai, Ning
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 576
container_issue 2
container_start_page 568
container_title Digestive diseases and sciences
container_volume 66
creator Xu, Mengque
Cen, Mengsha
Shen, Yuqin
Zhu, Yubin
Cheng, Fangli
Tang, Linlin
Hu, Weiling
Dai, Ning
description Background A Western diet is a risk factor for the development of inflammatory bowel disease (IBD). High levels of fecal deoxycholic acid (DCA) in response to a Western diet contribute to bowel inflammatory injury. However, the mechanism of DCA in the natural course of IBD development remains unanswered. Aims The aim of this study is to investigate the effect of DCA on the induction of gut dysbiosis and its roles in the development of intestinal inflammation. Methods Wild-type C57BL/6J mice were fed an AIN-93G diet, either supplemented with or without 0.2% DCA, and killed at 24 weeks. Distal ileum and colon tissues were assessed by histopathological analysis. Hepatic and ileal gene expression was examined by qPCR, and the gut microbiota was analyzed by high-throughput 16S rRNA gene sequencing. HPLC–MS was used for fecal bile acid quantification. Results Mice fed the DCA-supplemented diet developed focal areas of ileal and colonic inflammation, accompanied by alteration of the composition of the intestinal microbiota and accumulation of fecal bile acids. DCA-induced dysbiosis decreased the deconjugation of bile acids, and this regulation was associated with the repressed expression of target genes in the enterohepatic farnesoid X receptor–fibroblast growth factor (FXR–FGF15) axis, leading to upregulation of hepatic de novo bile acid synthesis. Conclusions These results suggest that DCA-induced gut dysbiosis may act as a key etiologic factor in intestinal inflammation, associated with bile acid metabolic disturbance and downregulation of the FXR–FGF15 axis.
doi_str_mv 10.1007/s10620-020-06208-3
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2486621160</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A712933694</galeid><sourcerecordid>A712933694</sourcerecordid><originalsourceid>FETCH-LOGICAL-c508t-ffd360967bd26fb215efc2822705dd669baaa6868838ad867f7804b4c61baded3</originalsourceid><addsrcrecordid>eNp9kVtr3DAQhUVpaTZp_0AegqDPTnRZj-TH7W4uC4H2oX0Wsi6Jgm1tJRuy_z5yNm0IhCIGHdB3htEchE4pOaeEiItMCTBSkbmKkBX_gBa0FrxiNciPaEEoFE0pHKHjnB8IIY2g8BkdcUYbWYNYoMeNi497cx-7YPDKBFttBzsZZ_H1NOLNPrch5pDxJuQ07caMv4fOPYP4chhdivdup8fiXYdkpq7IOGA9WPwzxT6OLuNtwfIYBt0V6Tvd98_QF_TJ6y67ry_3Cfp9dflrfVPd_rjerle3lamJHCvvLQfSgGgtA98yWjtvmGRMkNpagKbVWoMEKbnUVoLwQpJluzRAW22d5Sfo26HvLsU_U5lEPcQplWmyYksJMK-HvFJ3unMqDD6OSZs-ZKNWgrKGc2iWhTp_hyrHuj6YODhflvPWwA4Gk2LOyXm1S6HXaa8oUXOG6pChInPNGSpeTGcvE09t7-w_y9_QCsAPQC5Pw51Lr1_6T9snECunBA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2486621160</pqid></control><display><type>article</type><title>Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Xu, Mengque ; Cen, Mengsha ; Shen, Yuqin ; Zhu, Yubin ; Cheng, Fangli ; Tang, Linlin ; Hu, Weiling ; Dai, Ning</creator><creatorcontrib>Xu, Mengque ; Cen, Mengsha ; Shen, Yuqin ; Zhu, Yubin ; Cheng, Fangli ; Tang, Linlin ; Hu, Weiling ; Dai, Ning</creatorcontrib><description>Background A Western diet is a risk factor for the development of inflammatory bowel disease (IBD). High levels of fecal deoxycholic acid (DCA) in response to a Western diet contribute to bowel inflammatory injury. However, the mechanism of DCA in the natural course of IBD development remains unanswered. Aims The aim of this study is to investigate the effect of DCA on the induction of gut dysbiosis and its roles in the development of intestinal inflammation. Methods Wild-type C57BL/6J mice were fed an AIN-93G diet, either supplemented with or without 0.2% DCA, and killed at 24 weeks. Distal ileum and colon tissues were assessed by histopathological analysis. Hepatic and ileal gene expression was examined by qPCR, and the gut microbiota was analyzed by high-throughput 16S rRNA gene sequencing. HPLC–MS was used for fecal bile acid quantification. Results Mice fed the DCA-supplemented diet developed focal areas of ileal and colonic inflammation, accompanied by alteration of the composition of the intestinal microbiota and accumulation of fecal bile acids. DCA-induced dysbiosis decreased the deconjugation of bile acids, and this regulation was associated with the repressed expression of target genes in the enterohepatic farnesoid X receptor–fibroblast growth factor (FXR–FGF15) axis, leading to upregulation of hepatic de novo bile acid synthesis. Conclusions These results suggest that DCA-induced gut dysbiosis may act as a key etiologic factor in intestinal inflammation, associated with bile acid metabolic disturbance and downregulation of the FXR–FGF15 axis.</description><identifier>ISSN: 0163-2116</identifier><identifier>EISSN: 1573-2568</identifier><identifier>DOI: 10.1007/s10620-020-06208-3</identifier><identifier>PMID: 32198567</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Acids ; Analysis ; Animals ; Bile ; Bile Acids and Salts - metabolism ; Biochemistry ; Deoxycholic acid ; Deoxycholic Acid - administration &amp; dosage ; Deoxycholic Acid - toxicity ; Development and progression ; Diet, Western - adverse effects ; Dysbiosis - chemically induced ; Dysbiosis - metabolism ; Dysbiosis - pathology ; Enterohepatic Circulation - drug effects ; Enterohepatic Circulation - physiology ; Feces ; Fibroblast growth factors ; Gastroenterology ; Gastrointestinal diseases ; Gastrointestinal Microbiome - drug effects ; Gastrointestinal Microbiome - physiology ; Gene expression ; Hepatology ; Inflammation ; Inflammatory bowel disease ; Inflammatory Bowel Diseases - chemically induced ; Inflammatory Bowel Diseases - metabolism ; Inflammatory Bowel Diseases - pathology ; Medicine ; Medicine &amp; Public Health ; Mice ; Mice, Inbred C57BL ; Microbiota ; Microbiota (Symbiotic organisms) ; Oncology ; Original Article ; Risk factors ; RNA ; Transplant Surgery</subject><ispartof>Digestive diseases and sciences, 2021-02, Vol.66 (2), p.568-576</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020</rights><rights>COPYRIGHT 2021 Springer</rights><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c508t-ffd360967bd26fb215efc2822705dd669baaa6868838ad867f7804b4c61baded3</citedby><cites>FETCH-LOGICAL-c508t-ffd360967bd26fb215efc2822705dd669baaa6868838ad867f7804b4c61baded3</cites><orcidid>0000-0001-8476-6625</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10620-020-06208-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10620-020-06208-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27922,27923,41486,42555,51317</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32198567$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xu, Mengque</creatorcontrib><creatorcontrib>Cen, Mengsha</creatorcontrib><creatorcontrib>Shen, Yuqin</creatorcontrib><creatorcontrib>Zhu, Yubin</creatorcontrib><creatorcontrib>Cheng, Fangli</creatorcontrib><creatorcontrib>Tang, Linlin</creatorcontrib><creatorcontrib>Hu, Weiling</creatorcontrib><creatorcontrib>Dai, Ning</creatorcontrib><title>Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation</title><title>Digestive diseases and sciences</title><addtitle>Dig Dis Sci</addtitle><addtitle>Dig Dis Sci</addtitle><description>Background A Western diet is a risk factor for the development of inflammatory bowel disease (IBD). High levels of fecal deoxycholic acid (DCA) in response to a Western diet contribute to bowel inflammatory injury. However, the mechanism of DCA in the natural course of IBD development remains unanswered. Aims The aim of this study is to investigate the effect of DCA on the induction of gut dysbiosis and its roles in the development of intestinal inflammation. Methods Wild-type C57BL/6J mice were fed an AIN-93G diet, either supplemented with or without 0.2% DCA, and killed at 24 weeks. Distal ileum and colon tissues were assessed by histopathological analysis. Hepatic and ileal gene expression was examined by qPCR, and the gut microbiota was analyzed by high-throughput 16S rRNA gene sequencing. HPLC–MS was used for fecal bile acid quantification. Results Mice fed the DCA-supplemented diet developed focal areas of ileal and colonic inflammation, accompanied by alteration of the composition of the intestinal microbiota and accumulation of fecal bile acids. DCA-induced dysbiosis decreased the deconjugation of bile acids, and this regulation was associated with the repressed expression of target genes in the enterohepatic farnesoid X receptor–fibroblast growth factor (FXR–FGF15) axis, leading to upregulation of hepatic de novo bile acid synthesis. Conclusions These results suggest that DCA-induced gut dysbiosis may act as a key etiologic factor in intestinal inflammation, associated with bile acid metabolic disturbance and downregulation of the FXR–FGF15 axis.</description><subject>Acids</subject><subject>Analysis</subject><subject>Animals</subject><subject>Bile</subject><subject>Bile Acids and Salts - metabolism</subject><subject>Biochemistry</subject><subject>Deoxycholic acid</subject><subject>Deoxycholic Acid - administration &amp; dosage</subject><subject>Deoxycholic Acid - toxicity</subject><subject>Development and progression</subject><subject>Diet, Western - adverse effects</subject><subject>Dysbiosis - chemically induced</subject><subject>Dysbiosis - metabolism</subject><subject>Dysbiosis - pathology</subject><subject>Enterohepatic Circulation - drug effects</subject><subject>Enterohepatic Circulation - physiology</subject><subject>Feces</subject><subject>Fibroblast growth factors</subject><subject>Gastroenterology</subject><subject>Gastrointestinal diseases</subject><subject>Gastrointestinal Microbiome - drug effects</subject><subject>Gastrointestinal Microbiome - physiology</subject><subject>Gene expression</subject><subject>Hepatology</subject><subject>Inflammation</subject><subject>Inflammatory bowel disease</subject><subject>Inflammatory Bowel Diseases - chemically induced</subject><subject>Inflammatory Bowel Diseases - metabolism</subject><subject>Inflammatory Bowel Diseases - pathology</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Microbiota</subject><subject>Microbiota (Symbiotic organisms)</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Risk factors</subject><subject>RNA</subject><subject>Transplant Surgery</subject><issn>0163-2116</issn><issn>1573-2568</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kVtr3DAQhUVpaTZp_0AegqDPTnRZj-TH7W4uC4H2oX0Wsi6Jgm1tJRuy_z5yNm0IhCIGHdB3htEchE4pOaeEiItMCTBSkbmKkBX_gBa0FrxiNciPaEEoFE0pHKHjnB8IIY2g8BkdcUYbWYNYoMeNi497cx-7YPDKBFttBzsZZ_H1NOLNPrch5pDxJuQ07caMv4fOPYP4chhdivdup8fiXYdkpq7IOGA9WPwzxT6OLuNtwfIYBt0V6Tvd98_QF_TJ6y67ry_3Cfp9dflrfVPd_rjerle3lamJHCvvLQfSgGgtA98yWjtvmGRMkNpagKbVWoMEKbnUVoLwQpJluzRAW22d5Sfo26HvLsU_U5lEPcQplWmyYksJMK-HvFJ3unMqDD6OSZs-ZKNWgrKGc2iWhTp_hyrHuj6YODhflvPWwA4Gk2LOyXm1S6HXaa8oUXOG6pChInPNGSpeTGcvE09t7-w_y9_QCsAPQC5Pw51Lr1_6T9snECunBA</recordid><startdate>20210201</startdate><enddate>20210201</enddate><creator>Xu, Mengque</creator><creator>Cen, Mengsha</creator><creator>Shen, Yuqin</creator><creator>Zhu, Yubin</creator><creator>Cheng, Fangli</creator><creator>Tang, Linlin</creator><creator>Hu, Weiling</creator><creator>Dai, Ning</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><orcidid>https://orcid.org/0000-0001-8476-6625</orcidid></search><sort><creationdate>20210201</creationdate><title>Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation</title><author>Xu, Mengque ; Cen, Mengsha ; Shen, Yuqin ; Zhu, Yubin ; Cheng, Fangli ; Tang, Linlin ; Hu, Weiling ; Dai, Ning</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c508t-ffd360967bd26fb215efc2822705dd669baaa6868838ad867f7804b4c61baded3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acids</topic><topic>Analysis</topic><topic>Animals</topic><topic>Bile</topic><topic>Bile Acids and Salts - metabolism</topic><topic>Biochemistry</topic><topic>Deoxycholic acid</topic><topic>Deoxycholic Acid - administration &amp; dosage</topic><topic>Deoxycholic Acid - toxicity</topic><topic>Development and progression</topic><topic>Diet, Western - adverse effects</topic><topic>Dysbiosis - chemically induced</topic><topic>Dysbiosis - metabolism</topic><topic>Dysbiosis - pathology</topic><topic>Enterohepatic Circulation - drug effects</topic><topic>Enterohepatic Circulation - physiology</topic><topic>Feces</topic><topic>Fibroblast growth factors</topic><topic>Gastroenterology</topic><topic>Gastrointestinal diseases</topic><topic>Gastrointestinal Microbiome - drug effects</topic><topic>Gastrointestinal Microbiome - physiology</topic><topic>Gene expression</topic><topic>Hepatology</topic><topic>Inflammation</topic><topic>Inflammatory bowel disease</topic><topic>Inflammatory Bowel Diseases - chemically induced</topic><topic>Inflammatory Bowel Diseases - metabolism</topic><topic>Inflammatory Bowel Diseases - pathology</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Microbiota</topic><topic>Microbiota (Symbiotic organisms)</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Risk factors</topic><topic>RNA</topic><topic>Transplant Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xu, Mengque</creatorcontrib><creatorcontrib>Cen, Mengsha</creatorcontrib><creatorcontrib>Shen, Yuqin</creatorcontrib><creatorcontrib>Zhu, Yubin</creatorcontrib><creatorcontrib>Cheng, Fangli</creatorcontrib><creatorcontrib>Tang, Linlin</creatorcontrib><creatorcontrib>Hu, Weiling</creatorcontrib><creatorcontrib>Dai, Ning</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Digestive diseases and sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xu, Mengque</au><au>Cen, Mengsha</au><au>Shen, Yuqin</au><au>Zhu, Yubin</au><au>Cheng, Fangli</au><au>Tang, Linlin</au><au>Hu, Weiling</au><au>Dai, Ning</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation</atitle><jtitle>Digestive diseases and sciences</jtitle><stitle>Dig Dis Sci</stitle><addtitle>Dig Dis Sci</addtitle><date>2021-02-01</date><risdate>2021</risdate><volume>66</volume><issue>2</issue><spage>568</spage><epage>576</epage><pages>568-576</pages><issn>0163-2116</issn><eissn>1573-2568</eissn><abstract>Background A Western diet is a risk factor for the development of inflammatory bowel disease (IBD). High levels of fecal deoxycholic acid (DCA) in response to a Western diet contribute to bowel inflammatory injury. However, the mechanism of DCA in the natural course of IBD development remains unanswered. Aims The aim of this study is to investigate the effect of DCA on the induction of gut dysbiosis and its roles in the development of intestinal inflammation. Methods Wild-type C57BL/6J mice were fed an AIN-93G diet, either supplemented with or without 0.2% DCA, and killed at 24 weeks. Distal ileum and colon tissues were assessed by histopathological analysis. Hepatic and ileal gene expression was examined by qPCR, and the gut microbiota was analyzed by high-throughput 16S rRNA gene sequencing. HPLC–MS was used for fecal bile acid quantification. Results Mice fed the DCA-supplemented diet developed focal areas of ileal and colonic inflammation, accompanied by alteration of the composition of the intestinal microbiota and accumulation of fecal bile acids. DCA-induced dysbiosis decreased the deconjugation of bile acids, and this regulation was associated with the repressed expression of target genes in the enterohepatic farnesoid X receptor–fibroblast growth factor (FXR–FGF15) axis, leading to upregulation of hepatic de novo bile acid synthesis. Conclusions These results suggest that DCA-induced gut dysbiosis may act as a key etiologic factor in intestinal inflammation, associated with bile acid metabolic disturbance and downregulation of the FXR–FGF15 axis.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>32198567</pmid><doi>10.1007/s10620-020-06208-3</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-8476-6625</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0163-2116
ispartof Digestive diseases and sciences, 2021-02, Vol.66 (2), p.568-576
issn 0163-2116
1573-2568
language eng
recordid cdi_proquest_journals_2486621160
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Acids
Analysis
Animals
Bile
Bile Acids and Salts - metabolism
Biochemistry
Deoxycholic acid
Deoxycholic Acid - administration & dosage
Deoxycholic Acid - toxicity
Development and progression
Diet, Western - adverse effects
Dysbiosis - chemically induced
Dysbiosis - metabolism
Dysbiosis - pathology
Enterohepatic Circulation - drug effects
Enterohepatic Circulation - physiology
Feces
Fibroblast growth factors
Gastroenterology
Gastrointestinal diseases
Gastrointestinal Microbiome - drug effects
Gastrointestinal Microbiome - physiology
Gene expression
Hepatology
Inflammation
Inflammatory bowel disease
Inflammatory Bowel Diseases - chemically induced
Inflammatory Bowel Diseases - metabolism
Inflammatory Bowel Diseases - pathology
Medicine
Medicine & Public Health
Mice
Mice, Inbred C57BL
Microbiota
Microbiota (Symbiotic organisms)
Oncology
Original Article
Risk factors
RNA
Transplant Surgery
title Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A49%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Deoxycholic%20Acid-Induced%20Gut%20Dysbiosis%20Disrupts%20Bile%20Acid%20Enterohepatic%20Circulation%20and%20Promotes%20Intestinal%20Inflammation&rft.jtitle=Digestive%20diseases%20and%20sciences&rft.au=Xu,%20Mengque&rft.date=2021-02-01&rft.volume=66&rft.issue=2&rft.spage=568&rft.epage=576&rft.pages=568-576&rft.issn=0163-2116&rft.eissn=1573-2568&rft_id=info:doi/10.1007/s10620-020-06208-3&rft_dat=%3Cgale_proqu%3EA712933694%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2486621160&rft_id=info:pmid/32198567&rft_galeid=A712933694&rfr_iscdi=true